Partial Seizures

• CLINICAL_TRIALS trial_result · 2007-11-30
  Clinical Trial Update: Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures [Phase 4]

  Phase 4 trial results evaluate the safety and efficacy of oxcarbazepine as monotherapy in adults with partial seizures.

• FDA approval · 2007-10-09
  FDA Approved: OXCARBAZEPINE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries' original application for a generic oxcarbazepine product. This marks approval of a generic versi…

• CLINICAL_TRIALS trial_result · 2007-05-21
  Clinical Trial Update: A Study for Treatment of Partial Seizures in Children [Phase 3]

  Phase 3 clinical trial update for the treatment of partial seizures in children; the study has completed.

• CLINICAL_TRIALS trial_result · 2007-01-01
  Clinical Trial Update: To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. [Phase 3]

  This update reports the completion of a Phase 3 trial evaluating the long-term safety and efficacy of pregabalin in patients with partial se…

• CLINICAL_TRIALS trial_result · 2007-01-01
  Clinical Trial Update: To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. [Phase 3]

  A Phase 3 clinical trial assessing the long-term safety and efficacy of pregabalin in patients with partial seizures has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-11-20
  FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

  FDA approved a supplemental application for Zonegran (zonisamide) submitted by Advanz Pharma (US) Corp.

• CLINICAL_TRIALS trial_result · 2006-07-24
  Clinical Trial Update: Pregabalin Open-Label Extension Trial in Patients With Partial Seizures [Phase 3]

  Pfizer reports the completion of an open-label Phase 3 extension trial of pregabalin in patients with partial seizures.

• FDA approval · 2006-05-31
  FDA Approved: ZONISAMIDE — Original Application (Exelan Pharmaceuticals, Inc.)

  The FDA approved Exelan Pharmaceuticals' original (ANDA) application for zonisamide, enabling a generic version of the anticonvulsant for us…